Literature DB >> 20833979

Adaptation to anemia in hemoglobin E-ß thalassemia.

Angela Allen1, Christopher Fisher, Anuja Premawardhena, Timothy Peto, Stephen Allen, Mahinda Arambepola, Vivekanandan Thayalsutha, Nancy Olivieri, David Weatherall.   

Abstract

Hemoglobin E β thalassemia is the commonest form of severe thalassemia in many Asian countries. Its remarkably variable clinical phenotype presents a major challenge to determining its most appropriate management. In particular, it is not clear why some patients with this condition can develop and function well at very low hemoglobin levels. Here, we demonstrate that patients with hemoglobin Eβ thalassemia have a significant decrease in the oxygen affinity of their hemoglobin, that is an increased P(50) value, in response to anemia. This may in part reflect the lower level of hemoglobin F in this condition compared with other forms of β thalassemia intermedia. The ability to right-shift the oxygen dissociation curve was retained across the spectrum of mild and severe phenotypes, despite the significantly higher levels of hemoglobin F in the former, suggesting that efforts directed at producing a modest increase in the level of hemoglobin F in symptomatic patients with this disease should be of therapeutic value.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833979     DOI: 10.1182/blood-2010-06-289488

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

2.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

Review 3.  The transfusion management of beta thalassemia in the United States.

Authors:  Ashutosh Lal; Trisha Wong; Siobán Keel; Monica Pagano; Jong Chung; Aditi Kamdar; Latha Rao; Alan Ikeda; Geetha Puthenveetil; Sanjay Shah; Jennifer Yu; Elliott Vichinsky
Journal:  Transfusion       Date:  2021-08-28       Impact factor: 3.337

Review 4.  Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.

Authors:  Vikita Mehta; Abirami Kirubarajan; Amir Sabouhanian; Sanasi M Jayawardena; Priya Chandrakumaran; Nila Thangavelu; Refai Cader; Sachith Mettananda; Dayananda Bandara; Shawn Khan; David J Weatherall; Angela Allen; Anuja P Premawardhena; Nancy F Olivieri
Journal:  Acta Haematol       Date:  2021-11-09       Impact factor: 3.068

Review 5.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

6.  Methemoglobinemia and ascorbate deficiency in hemoglobin E β thalassemia: metabolic and clinical implications.

Authors:  Angela Allen; Christopher Fisher; Anuja Premawardhena; Dayananda Bandara; Ashok Perera; Stephen Allen; Timothy St Pierre; Nancy Olivieri; David Weatherall
Journal:  Blood       Date:  2012-08-10       Impact factor: 22.113

Review 7.  Management of the thalassemias.

Authors:  Nancy F Olivieri; Gary M Brittenham
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 8.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

9.  Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

Authors:  Emma Jones; Sant-Rayn Pasricha; Angela Allen; Patricia Evans; Chris A Fisher; Katherine Wray; Anuja Premawardhena; Dyananda Bandara; Ashok Perera; Craig Webster; Pamela Sturges; Nancy F Olivieri; Timothy St Pierre; Andrew E Armitage; John B Porter; David J Weatherall; Hal Drakesmith
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

Review 10.  A journey in science: early lessons from the hemoglobin field.

Authors:  David J Weatherall
Journal:  Mol Med       Date:  2014-11-11       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.